Envestnet Asset Management Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$14.37 - $19.07 $254,018 - $337,100
-17,677 Reduced 54.92%
14,509 $254,000
Q3 2023

Nov 13, 2023
SELL
$13.62 - $20.2 $267,578 - $396,849
-19,646 Reduced 37.9%
32,186 $559,000
Q2 2023

Aug 04, 2023
SELL
$10.44 - $16.48 $2.3 Million - $3.63 Million
-220,494 Reduced 80.97%
51,832 $729,000
Q1 2023

May 11, 2023
BUY
$10.7 - $15.79 $2.91 Million - $4.3 Million
272,326 New
272,326 $2.93 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email